{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:07:38Z","timestamp":1794269258649,"version":"4.9.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Foot"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.foot.2022.101909","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T02:33:43Z","timestamp":1643942023000},"page":"101909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"special_numbering":"C","title":["Health economics of diabetic foot ulcer and recent trends to accelerate treatment"],"prefix":"10.1016","volume":"52","author":[{"given":"Abha","family":"Jodheea-Jutton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Hindocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Bhaw-Luximon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.foot.2022.101909_bib0005","series-title":"IDF diabetes atlas","first-page":"14","author":"International Diabetes Federation","year":"2019"},{"issue":"5","key":"10.1016\/j.foot.2022.101909_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1479164116651390","article-title":"The prevalence of major lower limb amputation in the diabetic and non-diabetic population of England 2003-2013","volume":"13","author":"Ahmad","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"issue":"February (2)","key":"10.1016\/j.foot.2022.101909_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"issue":"July (7)","key":"10.1016\/j.foot.2022.101909_bib0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.22.7.1029","article-title":"Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers","volume":"22","author":"Adler","year":"1999","journal-title":"Diabetes Care"},{"issue":"November (9498)","key":"10.1016\/j.foot.2022.101909_bib0025","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"issue":"April (4)","key":"10.1016\/j.foot.2022.101909_bib0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the U.S. In 2012","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"April (4)","key":"10.1016\/j.foot.2022.101909_bib0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/dc17-1836","article-title":"Current challenges and opportunities in the prevention and management of diabetic foot ulcers","volume":"41","author":"Jeffcoate","year":"2018","journal-title":"Diabetes Care"},{"issue":"April (4)","key":"10.1016\/j.foot.2022.101909_bib0040","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jdiacomp.2016.12.017","article-title":"A model to estimate cost-savings in diabetic foot ulcer prevention efforts","volume":"31","author":"Barshes","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"September (9)","key":"10.1016\/j.foot.2022.101909_bib0045","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/diacare.23.9.1333","article-title":"A cost analysis of diabetic lower-extremity ulcers","volume":"23","author":"Harrington","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.foot.2022.101909_bib0050","series-title":"Economic burden of diabetic foot ulcers and amputations: Data Points #3. Data Points Publication Series","author":"Margolis","year":"2011"},{"issue":"September (5)","key":"10.1016\/j.foot.2022.101909_bib0055","first-page":"968","article-title":"Estimated costs of the treatment of diabetic foot ulcers in a tertiary hospital in Turkey","volume":"30","author":"Keskek","year":"2014","journal-title":"Pakistan J Med Sci"},{"issue":"March (3)","key":"10.1016\/j.foot.2022.101909_bib0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for medicare and private insurers","volume":"37","author":"Rice","year":"2014","journal-title":"Diabetes Care"},{"issue":"January","key":"10.1016\/j.foot.2022.101909_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12913-015-0687-5","article-title":"Economic burden of illness associated with diabetic foot ulcers in Canada","volume":"15","author":"Hopkins","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"February (1)","key":"10.1016\/j.foot.2022.101909_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/iwj.12816","article-title":"Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes","volume":"15","author":"Guest","year":"2018","journal-title":"Int Wound J"},{"issue":"October (10)","key":"10.1016\/j.foot.2022.101909_bib0075","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s00125-008-1089-6","article-title":"Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.foot.2022.101909_bib0080","series-title":"Diabetes\/metabolism research and reviews","article-title":"Cost of treating diabetic foot ulcers in five different countries","author":"Cavanagh","year":"2012"},{"issue":"August (Supplement_2)","key":"10.1016\/j.foot.2022.101909_bib0085","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1086\/383275","article-title":"Health-economic consequences of diabetic foot lesions","volume":"39","author":"Ragnarson Tennvall","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"September (3)","key":"10.1016\/j.foot.2022.101909_bib0090","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/j.jvs.2010.06.003","article-title":"The costs of diabetic foot: the economic case for the limb salvage team","volume":"52","author":"Driver","year":"2010","journal-title":"J Vasc Surg"},{"issue":"August (8)","key":"10.1016\/j.foot.2022.101909_bib0095","doi-asserted-by":"crossref","first-page":"e0134914","DOI":"10.1371\/journal.pone.0134914","article-title":"A diabetic emergency one million feet long: disparities and burdens of illness among diabetic foot ulcer cases within emergency departments in the United States, 2006\u20132010. Taheri S, editor","volume":"10","author":"Skrepnek","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.foot.2022.101909_bib0100","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s00125-008-1089-6","article-title":"Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"issue":"August (8)","key":"10.1016\/j.foot.2022.101909_bib0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/dme.13973","article-title":"The cost of diabetic foot ulcers and amputations to the National Health Service in England","volume":"36","author":"Kerr","year":"2019","journal-title":"Diabet Med"},{"issue":"January (1)","key":"10.1016\/j.foot.2022.101909_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2042018817744513","article-title":"Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always","volume":"9","author":"Raghav","year":"2018","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.foot.2022.101909_bib0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ando.2017.11.005","article-title":"Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: a systematic review","volume":"79","author":"Tchero","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.foot.2022.101909_bib0120","article-title":"Elevated costs and high one-year mortality in patients with diabetic foot ulcers after surgery","author":"S\u00f8ndergaard","year":"2015","journal-title":"Dan Med J"},{"key":"10.1016\/j.foot.2022.101909_bib0125","series-title":"DFA guides you through","author":"Australia","year":"2017"},{"issue":"December (12)","key":"10.1016\/j.foot.2022.101909_bib0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.47102\/annals-acadmedsg.V44N12p567","article-title":"Costs of patients admitted for diabetic foot problems","volume":"44","author":"Tan","year":"2015","journal-title":"Ann Acad Med Singapore"},{"issue":"April (2)","key":"10.1016\/j.foot.2022.101909_bib0135","first-page":"219","article-title":"Prevalence and healthcare costs associated with the management of diabetic foot ulcer in patients attending Ahmadu Bello University Teaching Hospital, Nigeria","volume":"10","author":"Danmusa","year":"2016","journal-title":"Int J Health Sci (Qassim)"},{"issue":"October (18)","key":"10.1016\/j.foot.2022.101909_bib0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4239\/wjd.v7.i18.462","article-title":"Cost of illness among patients with diabetic foot ulcer in Turkey","volume":"7","author":"Oksuz","year":"2016","journal-title":"World J Diabetes"},{"issue":"October (11)","key":"10.1016\/j.foot.2022.101909_bib0145","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1742-1241.2007.01534.x","article-title":"Assessment and treatment of diabetic foot ulcer","volume":"61","author":"Fard","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"October (9)","key":"10.1016\/j.foot.2022.101909_bib0150","doi-asserted-by":"crossref","first-page":"A485","DOI":"10.1016\/j.jval.2017.08.489","article-title":"Burden of diabetic foot ulcers in India: evidence landscape from published literature","volume":"20","author":"Ghosh","year":"2017","journal-title":"Value Heal"},{"issue":"9","key":"10.1016\/j.foot.2022.101909_bib0155","first-page":"1","article-title":"Current perspective in the management of diabetic foot ulcers - an overview on the Indian scenario","volume":"6","author":"Karri","year":"2014","journal-title":"Int J Pharm Pharm Sci"},{"issue":"October (10)","key":"10.1016\/j.foot.2022.101909_bib0160","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1464-5491.2008.02529.x","article-title":"The personal cost of diabetic foot disease in the developing world-a study from Pakistan","volume":"25","author":"Ali","year":"2008","journal-title":"Diabet Med"},{"issue":"January (1)","key":"10.1016\/j.foot.2022.101909_bib0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1464-5491.2009.02871.x","article-title":"Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country-a simulation of the current situation in Brazil","volume":"27","author":"Rezende","year":"2010","journal-title":"Diabet Med"},{"issue":"January (1)","key":"10.1016\/j.foot.2022.101909_bib0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(14)70240-2","article-title":"Country in focus: turning the tide of diabetes in Fiji","volume":"3","author":"Morgan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"January (1)","key":"10.1016\/j.foot.2022.101909_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12992-017-0318-5","article-title":"Cost of diabetes mellitus in Africa: a systematic review of existing literature","volume":"14","author":"Mutyambizi","year":"2018","journal-title":"Global Health"},{"issue":"October","key":"10.1016\/j.foot.2022.101909_bib0180","first-page":"135","article-title":"Managing the diabetic foot in resource-poor settings: challenges and solutions","volume":"4","author":"Abbas","year":"2017","journal-title":"Chronic Wound Care Manag Res"},{"issue":"August (4)","key":"10.1016\/j.foot.2022.101909_bib0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/ten.teb.2017.0477","article-title":"A universal classification system of skin substitutes inspired by factorial design","volume":"24","author":"Davison-Kotler","year":"2018","journal-title":"Tissue Eng B Rev"},{"issue":"September (3)","key":"10.1016\/j.foot.2022.101909_bib0190","first-page":"356","article-title":"Wound healing: biologics, skin substitutes, biomembranes and scaffolds","volume":"2","author":"Vyas","year":"2014","journal-title":"Healthc (Basel, Switzerland)"},{"issue":"August (8)","key":"10.1016\/j.foot.2022.101909_bib0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1089\/wound.2014.0604","article-title":"The use of biologic scaffolds in the treatment of chronic nonhealing wounds","volume":"4","author":"Turner","year":"2015","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.foot.2022.101909_bib0200","series-title":"Trends in biotechnology","first-page":"638","article-title":"Skin regeneration scaffolds: a multimodal bottom-up approach","author":"Yildirimer","year":"2012"},{"issue":"July (4)","key":"10.1016\/j.foot.2022.101909_bib0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12434","article-title":"Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: highlights of a Cochrane systematic review","volume":"24","author":"Santema","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"March (1)","key":"10.1016\/j.foot.2022.101909_bib0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1534734618818301","article-title":"Allogeneic skin substitutes versus human placental membrane products in the management of diabetic foot ulcers: a narrative comparative evaluation of the literature","volume":"18","author":"Luck","year":"2019","journal-title":"Int J Low Extrem Wounds"},{"issue":"June (3)","key":"10.1016\/j.foot.2022.101909_bib0215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/wound.2011.0282","article-title":"Use in the treatment of chronic wounds","volume":"1","author":"Hart","year":"2012","journal-title":"Adv Wound Care"},{"issue":"August (8)","key":"10.1016\/j.foot.2022.101909_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.ASW.0000451891.87020.69","article-title":"The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers","volume":"27","author":"Kavros","year":"2014","journal-title":"Adv Skin Wound Care"},{"issue":"1","key":"10.1016\/j.foot.2022.101909_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i1.10","article-title":"Scaffold: a novel carrier for cell and drug delivery","volume":"29","author":"Garg","year":"2012","journal-title":"Crit Rev Ther Drug Carr Syst"},{"issue":"February (2)","key":"10.1016\/j.foot.2022.101909_bib0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/wound.2014.0600","article-title":"Challenges and opportunities in drug delivery for wound healing","volume":"5","author":"Whittam","year":"2016","journal-title":"Adv Wound Care"},{"issue":"May (8)","key":"10.1016\/j.foot.2022.101909_bib0235","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/0885328210390402","article-title":"Glucose oxidase incorporated collagen matrices for dermal wound repair in diabetic rat models: a biochemical study","volume":"26","author":"Arul","year":"2012","journal-title":"J Biomater Appl"},{"issue":"September (6)","key":"10.1016\/j.foot.2022.101909_bib0240","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/GOX.0b013e3182a88787","article-title":"The effect of control-released basic fibroblast growth factor in wound healing: histological analyses and clinical application","volume":"1","author":"Matsumoto","year":"2013","journal-title":"Plast Reconstr surgery Glob open"},{"issue":"1","key":"10.1016\/j.foot.2022.101909_bib0245","article-title":"Efficacy of the controlled release of concentrated platelet lysate from a Collagen\/Gelatin scaffold for dermis-like tissue regeneration","volume":"19","author":"Ito","year":"2013","journal-title":"Tissue Eng"},{"issue":"April (3)","key":"10.1016\/j.foot.2022.101909_bib0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/wound.2011.0327","article-title":"siRNA delivery from an injectable scaffold for wound therapy","volume":"2","author":"Nelson","year":"2013","journal-title":"Adv Wound Care"},{"issue":"September","key":"10.1016\/j.foot.2022.101909_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.omtn.2017.06.003","article-title":"MicroRNA as therapeutic targets for chronic wound healing","volume":"8","author":"Mulholland","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"March (9)","key":"10.1016\/j.foot.2022.101909_bib0260","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/adma.201503565","article-title":"Self-assembled wound dressings silence MMP-9 and improve diabetic wound healing in vivo","volume":"28","author":"Castleberry","year":"2016","journal-title":"Adv Mater"},{"key":"10.1016\/j.foot.2022.101909_bib0265","first-page":"1","article-title":"Nanohybrid scaffolds for the treatment of diabetic wounds","author":"Karri","year":"2017","journal-title":"Springer, Cham"},{"key":"10.1016\/j.foot.2022.101909_bib0270","series-title":"Nano- and microscale drug delivery systems: design and fabrication","first-page":"147","article-title":"Electrospun nanofibrous scaffold as a potential carrier of antimicrobial therapeutics for diabetic wound healing and tissue regeneration","author":"Dwivedi","year":"2017"},{"issue":"March (3)","key":"10.1016\/j.foot.2022.101909_bib0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1369-7021(11)70058-X","article-title":"Biomaterials & scaffolds for tissue engineering","volume":"14","author":"O\u2019Brien","year":"2011","journal-title":"Mater Today"},{"issue":"October (10)","key":"10.1016\/j.foot.2022.101909_bib0280","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2337\/diacare.26.10.2853","article-title":"HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial","volume":"26","author":"Caravaggi","year":"2003","journal-title":"Diabetes Care"},{"issue":"June (2)","key":"10.1016\/j.foot.2022.101909_bib0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1534734611409371","article-title":"Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up","volume":"10","author":"Uccioli","year":"2011","journal-title":"Int J Low Extrem Wounds"},{"issue":"March (3)","key":"10.1016\/j.foot.2022.101909_bib0290","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.22.3.382","article-title":"Incidence, outcomes, and cost of foot ulcers in patients with diabetes","volume":"22","author":"Ramsey","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.foot.2022.101909_bib0295","series-title":"Are tissue replacements cost effective? | Podiatry today","first-page":"64","author":"Hanft","year":"2003"},{"issue":"3","key":"10.1016\/j.foot.2022.101909_bib0300","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/wound.2011.0282","article-title":"WOUND CARE PRODUCTS Dermagraft: use in the treatment of chronic wounds","volume":"1","author":"Hart","year":"2012","journal-title":"Adv Wound Care"},{"issue":"9","key":"10.1016\/j.foot.2022.101909_bib0305","first-page":"26","article-title":"A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft","volume":"60","author":"Sanders","year":"2014","journal-title":"Ostomy Wound Manag"},{"key":"10.1016\/j.foot.2022.101909_bib0310","first-page":"e10","article-title":"Healing rates in a multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management and an active comparator in the treatment of full-thickness diabetic foot ulcers","volume":"16","author":"Walters","year":"2016","journal-title":"Eplasty"},{"issue":"February","key":"10.1016\/j.foot.2022.101909_bib0315","first-page":"3","article-title":"Wiley InterScience :: JOURNALS :: International Wound Journal Side 1 af 2 Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers : a prospective, randomised, Wiley I","volume":"6","author":"Reyzelman","year":"2009","journal-title":"Int Wound J"},{"issue":"May (5)","key":"10.1016\/j.foot.2022.101909_bib0320","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jvs.2005.01.042","article-title":"Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial","volume":"41","author":"Mostow","year":"2005","journal-title":"J Vasc Surg"},{"issue":"Junuary (5 Pt 1)","key":"10.1016\/j.foot.2022.101909_bib0325","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00129334-200506000-00012","article-title":"Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers","volume":"18","author":"Niezgoda","year":"2005","journal-title":"Adv Skin Wound Care"},{"issue":"October (5)","key":"10.1016\/j.foot.2022.101909_bib0330","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/iwj.12097","article-title":"A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers","volume":"10","author":"Zelen","year":"2013","journal-title":"Int Wound J"},{"issue":"November (6)","key":"10.1016\/j.foot.2022.101909_bib0335","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/wrr.12357","article-title":"A clinical trial of Integra Template for diabetic foot ulcer treatment","volume":"23","author":"Driver","year":"2015","journal-title":"Wound Repair Regen"},{"issue":"October (5)","key":"10.1016\/j.foot.2022.101909_bib0340","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/iwj.12329","article-title":"The efficacy and safety of Grafix\u00ae for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial","volume":"11","author":"Lavery","year":"2014","journal-title":"Int Wound J"},{"issue":"July (7)","key":"10.1016\/j.foot.2022.101909_bib0345","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archsurg.137.7.822","article-title":"A randomized, controlled trial of Promogran (a collagen\/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers","volume":"137","author":"Veves","year":"2002","journal-title":"Arch Surg"},{"issue":"September (3)","key":"10.1016\/j.foot.2022.101909_bib0350","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1534734603258480","article-title":"A clinical investigation on the characteristics and outcomes of treating chronic lower extremity wounds using the tissuetech autograft system","volume":"2","author":"Uccioli","year":"2003","journal-title":"Int J Low Extrem Wounds"},{"issue":"December (6)","key":"10.1016\/j.foot.2022.101909_bib0355","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/iwj.12954","article-title":"Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients","volume":"15","author":"DiDomenico","year":"2018","journal-title":"Int Wound J"},{"issue":"27","key":"10.1016\/j.foot.2022.101909_bib0360","article-title":"Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot","volume":"27","author":"Vojta\u0161\u0161\u00e1k","year":"2006","journal-title":"Neuro Endocrinol Lett Neuroendocr Lett"},{"issue":"7","key":"10.1016\/j.foot.2022.101909_bib0365","doi-asserted-by":"crossref","DOI":"10.12968\/jowc.2013.22.7.369","article-title":"Collagen matrix wound dressings and the treatment of DFUs","volume":"22","author":"Haycocks","year":"2013","journal-title":"J Wound Care"},{"issue":"September (5)","key":"10.1016\/j.foot.2022.101909_bib0370","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12332","article-title":"Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting","volume":"23","author":"Kirsner","year":"2015","journal-title":"Wound Repair Regen"},{"issue":"April (2)","key":"10.1016\/j.foot.2022.101909_bib0375","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/iwj.12600","article-title":"A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers","volume":"14","author":"Zelen","year":"2017","journal-title":"Int Wound J"},{"issue":"October (25(Sup10))","key":"10.1016\/j.foot.2022.101909_bib0380","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.12968\/jowc.2016.25.Sup10.S8","article-title":"A comparative analysis of skin substitutes used in the management of diabetic foot ulcers","author":"Martinson","year":"2016","journal-title":"J Wound Care"},{"issue":"August (8)","key":"10.1016\/j.foot.2022.101909_bib0385","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3111\/13696998.2015.1031793","article-title":"Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers","volume":"18","author":"Rice","year":"2015","journal-title":"J Med Econ"},{"key":"10.1016\/j.foot.2022.101909_bib0390","series-title":"Symposium on Advanced Wound Care Spring","article-title":"A cost analysis of Two skin substitutes for treatment of large diabetic foot ulcers with exposed bone or tendon | Wounds research","author":"Samsell","year":"2019"},{"key":"10.1016\/j.foot.2022.101909_bib0395","series-title":"Innovative treatment of chronic diabetic foot ulcer in a ControlledRandomized clinical trial produces fewer adverse events, faster WoundClosure, and lower costs","author":"Nuccio","year":"2016"},{"issue":"February","key":"10.1016\/j.foot.2022.101909_bib0400","article-title":"Clinical characteristics of 82 death cases with COVID-19","author":"Zhang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.foot.2022.101909_bib0405","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"March","key":"10.1016\/j.foot.2022.101909_bib0410","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.foot.2022.101909_bib0415","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(20)30526-2","article-title":"COVID-19: the gendered impacts of the outbreak","volume":"395","author":"Wenham","year":"2020","journal-title":"Lancet"}],"container-title":["The Foot"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958259222000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958259222000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:29:51Z","timestamp":1760693391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958259222000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":83,"alternative-id":["S0958259222000062"],"URL":"https:\/\/doi.org\/10.1016\/j.foot.2022.101909","relation":{},"ISSN":["0958-2592"],"issn-type":[{"value":"0958-2592","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health economics of diabetic foot ulcer and recent trends to accelerate treatment","name":"articletitle","label":"Article Title"},{"value":"The Foot","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.foot.2022.101909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101909"}}